Age-related Macular Degeneration (AMD), the leading cause of blindness worldwide, is a multifactorial disease with mitochondrial dysfunction recognized as an early pathogenic event. In our preclinical studies, we demonstrated that a single Cerium-Oxide Nanoparticles (CeO2-NPs) intravitreal injection in a light-induced degeneration model, was able to counteract the retinal degeneration. Our aim was to investigate whether neuroprotection activity could be correlated with mitochondrial morpho-functional preservation. Bulk transcriptomic profiling of whole retinal tissue revealed that light-induced retinal injury was associated with suppression of mitochondrial-related gene networks, including components of the electron transport chain and regulators of mitochondrial dynamics, whereas CeO2-NPs treatment restored the expression of antioxidant and mitochondrial biogenesis-related genes. Ultrastructural analysis by electron microscopy showed preservation of Retinal Pigmented Epithelial mitochondria's morphology and by high-resolution crystallographic analysis confirmed the intracellular localization of CeO2-NPs in proximity to mitochondria. Furthermore, Western blot analysis demonstrated that CeO2-NPs maintained mitophagy markers at basal levels, preventing excessive activation of mitochondrial quality-control pathways. Together, these findings support mitochondrial preservation as a key mechanism underlying nanoceria-mediated retinal neuroprotection and highlight CeO2-NPs as promising candidates for maintaining retinal homeostasis in AMD.

Mitochondrial preservation underlies the antioxidant activity of nanoceria particles in light-induced retinal degeneration / Zerti, D., Donato, L., Chust, I.B., Carozza, G., Giangiulio, O., Stefanini, M., Faella, E., Feligioni, M., Di Gregorio, J., Flati, V., Carl, M., Poggi, L., D'Angelo, R., Passacantando, M., Maccarone, R.. - In: NANOMEDICINE. - ISSN 1549-9642. - 76:(2026), pp. 102995-102995. [10.1016/j.nano.2026.102995]

Mitochondrial preservation underlies the antioxidant activity of nanoceria particles in light-induced retinal degeneration

Chust, Ignacio Babiloni;Carl, Matthias;Poggi, Lucia;
2026-01-01

Abstract

Age-related Macular Degeneration (AMD), the leading cause of blindness worldwide, is a multifactorial disease with mitochondrial dysfunction recognized as an early pathogenic event. In our preclinical studies, we demonstrated that a single Cerium-Oxide Nanoparticles (CeO2-NPs) intravitreal injection in a light-induced degeneration model, was able to counteract the retinal degeneration. Our aim was to investigate whether neuroprotection activity could be correlated with mitochondrial morpho-functional preservation. Bulk transcriptomic profiling of whole retinal tissue revealed that light-induced retinal injury was associated with suppression of mitochondrial-related gene networks, including components of the electron transport chain and regulators of mitochondrial dynamics, whereas CeO2-NPs treatment restored the expression of antioxidant and mitochondrial biogenesis-related genes. Ultrastructural analysis by electron microscopy showed preservation of Retinal Pigmented Epithelial mitochondria's morphology and by high-resolution crystallographic analysis confirmed the intracellular localization of CeO2-NPs in proximity to mitochondria. Furthermore, Western blot analysis demonstrated that CeO2-NPs maintained mitophagy markers at basal levels, preventing excessive activation of mitochondrial quality-control pathways. Together, these findings support mitochondrial preservation as a key mechanism underlying nanoceria-mediated retinal neuroprotection and highlight CeO2-NPs as promising candidates for maintaining retinal homeostasis in AMD.
2026
Zerti, Darin; Donato, Luigi; Chust, Ignacio Babiloni; Carozza, Giulia; Giangiulio, Omar; Stefanini, Marta; Faella, Enver; Feligioni, Marco; Di Gregori...espandi
Mitochondrial preservation underlies the antioxidant activity of nanoceria particles in light-induced retinal degeneration / Zerti, D., Donato, L., Chust, I.B., Carozza, G., Giangiulio, O., Stefanini, M., Faella, E., Feligioni, M., Di Gregorio, J., Flati, V., Carl, M., Poggi, L., D'Angelo, R., Passacantando, M., Maccarone, R.. - In: NANOMEDICINE. - ISSN 1549-9642. - 76:(2026), pp. 102995-102995. [10.1016/j.nano.2026.102995]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11572/499810
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 0
  • OpenAlex ND
social impact